NCT02766673View on ClinicalTrials.gov

Aerosolized Albuterol Use in Severe BPD

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Severe Bronchopulmonary Dysplasia
Interventions
DRUG

Albuterol Sulfate

Subjects will receive a dose of study medication every 4 hours for 24 total hours

DRUG

Sterile Saline

Subjects will receive a dose of study medication every 4 hours for 24 total hours

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER

NCT02766673 - Aerosolized Albuterol Use in Severe BPD | Biotech Hunter | Biotech Hunter